ERBB2 and cancer: Noteworthy, using spheroid assays, which replicate several key features of solid tumors and are recognized as useful tools to investigate several anticancer treatments [33], we further confirmed that combining ebselen oxide with anti‐HER2 agents could provide a strong benefit as these combined treatments reached greater efficacy than molecules administrated separately to block HER2 signaling in HER2‐positive cancer cells.